Menu
GWAS Study

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.

Mahajan A, Taliun D, Thurner M et al.

30297969 PubMed ID
GWAS Study Type
574306 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MA
Mahajan A
TD
Taliun D
TM
Thurner M
RN
Robertson NR
TJ
Torres JM
RN
Rayner NW
PA
Payne AJ
SV
Steinthorsdottir V
SR
Scott RA
GN
Grarup N
CJ
Cook JP
SE
Schmidt EM
WM
Wuttke M
SC
Sarnowski C
MR
Mägi R
NJ
Nano J
GC
Gieger C
TS
Trompet S
LC
Lecoeur C
PM
Preuss MH
PB
Prins BP
GX
Guo X
BL
Bielak LF
BJ
Below JE
BD
Bowden DW
CJ
Chambers JC
KY
Kim YJ
NM
Ng MCY
PL
Petty LE
SX
Sim X
ZW
Zhang W
BA
Bennett AJ
BJ
Bork-Jensen J
BC
Brummett CM
CM
Canouil M
EK
Ec Kardt KU
FK
Fischer K
KS
Kardia SLR
KF
Kronenberg F
LK
Läll K
LC
Liu CT
LA
Locke AE
LJ
Luan J
NI
Ntalla I
NV
Nylander V
SS
Schönherr S
SC
Schurmann C
YL
Yengo L
BE
Bottinger EP
BI
Brandslund I
CC
Christensen C
DG
Dedoussis G
FJ
Florez JC
FI
Ford I
FO
Franco OH
FT
Frayling TM
GV
Giedraitis V
HS
Hackinger S
HA
Hattersley AT
HC
Herder C
IM
Ikram MA
IM
Ingelsson M
JM
Jørgensen ME
JT
Jørgensen T
KJ
Kriebel J
KJ
Kuusisto J
LS
Ligthart S
LC
Lindgren CM
LA
Linneberg A
LV
Lyssenko V
MV
Mamakou V
MT
Meitinger T
MK
Mohlke KL
MA
Morris AD
NG
Nadkarni G
PJ
Pankow JS
PA
Peters A
SN
Sattar N
SA
Stančáková A
SK
Strauch K
TK
Taylor KD
TB
Thorand B
TG
Thorleifsson G
TU
Thorsteinsdottir U
TJ
Tuomilehto J
WD
Witte DR
DJ
Dupuis J
PP
Peyser PA
ZE
Zeggini E
LR
Loos RJF
FP
Froguel P
IE
Ingelsson E
LL
Lind L
GL
Groop L
LM
Laakso M
CF
Collins FS
JJ
Jukema JW
PC
Palmer CNA
GH
Grallert H
MA
Metspalu A
DA
Dehghan A
KA
Köttgen A
AG
Abecasis GR
MJ
Meigs JB
RJ
Rotter JI
MJ
Marchini J
PO
Pedersen O
HT
Hansen T
LC
Langenberg C
WN
Wareham NJ
SK
Stefansson K
GA
Gloyn AL
MA
Morris AP
BM
Boehnke M
MM
McCarthy MI
Chapter II

Abstract

Summary of the research findings

We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130 European-descent individuals (9% cases), after imputation to high-density reference panels. With these data, we (i) extend the inventory of T2D-risk variants (243 loci, 135 newly implicated in T2D predisposition, comprising 403 distinct association signals); (ii) enrich discovery of lower-frequency risk alleles (80 index variants with minor allele frequency <5%, 14 with estimated allelic odds ratio >2); (iii) substantially improve fine-mapping of causal variants (at 51 signals, one variant accounted for >80% posterior probability of association (PPA)); (iv) extend fine-mapping through integration of tissue-specific epigenomic information (islet regulatory annotations extend the number of variants with PPA >80% to 73); (v) highlight validated therapeutic targets (18 genes with associations attributable to coding variants); and (vi) demonstrate enhanced potential for clinical translation (genome-wide chip heritability explains 18% of T2D risk; individuals in the extremes of a T2D polygenic risk score differ more than ninefold in prevalence).

50,409 European ancestry cases, 523,897 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

574306
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.